Phenytoin and Chlorpromazine in the Treatment of Spasticity

Archives of Neurology

Volumn 37, Issue 6, 1980, Pages 360-364

  Cohan, Stanley L ^a   Raines, Arthur ^a   Panagakos, Jean ^a   Armitage, Patricia ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; CHLORPROMAZINE; DANTROLENE; DIAZEPAM; PHENYTOIN;

CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MIXTURE; DRUG THERAPY; GAMMA SYSTEM; MAJOR CLINICAL STUDY; MUSCLE; MUSCLE SPINDLE; PERIPHERAL NERVOUS SYSTEM; PRELIMINARY COMMUNICATION; SPASTICITY; THERAPY;

ADULT; AGED; CHLORPROMAZINE; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; MALE; MIDDLE AGE; MOTOR NEURONS; MUSCLE SPASTICITY; MUSCLE TONUS; PHENYTOIN; SYNAPTIC TRANSMISSION;

EID: 0018850063     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1980.00500550062008     Document Type: Article

References (50)

1. 1. Matthews W, Rushworth G, Wakefield G: Dimethothiazine in spasticity: A further attempt at pharmacological control. Acta Neurol Scand 48:635-644, 1972.
2. 2. Landau WM: Spasticity: The fable of a neurological demon and the emperor's new therapy. Arch Neurol 31:217-219, 1974.
3. 3. Domino EF: Central skeletal muscle relaxants. Arch Phys Med Rehabil 55:369-373, 1971.
4. 4. Haefely WE: Synaptic pharmacology of barbiturates and benzodiazepines. Agents Actions 7:353-359, 1977.
5. 5. Calne DB: The pharmacology of spasticity, in Klawans HL (ed): Clinical Neuropharmacology. New York, Raven Press, vol 1, 1976, pp 137-145.
6. 6. Schmidt RT, Lee RH, Spehlmann R: Comparison of dantrolene sodium and diazepam in the treatment of spasticity. J Neurol Neurosurg Psychiatry 39:350-356, 1976.
7. 7. Ellis KO, Carpenter JF: Studies on the mechanism of action of dantrolene sodium: A skeletal muscle relaxant. Naunyn Schmiedebergs Arch Pharmacol 275:83-94, 1972.
8. 8. Ellis KO, Bryant SH: Excitation-contraction uncoupling in skeletal muscle by dantrolene sodium. Naunyn Schmiedebergs Arch Pharmacol 274:107-109, 1972.
9. 9. Putney JW Jr, Bianchi CP: Site of action of dantrolene in frog sartorius muscle. J Pharmacol Exp Ther 189:202-212, 1974.
10. 10. Pinder RM, Brogden RN, Speight TM, et al: Dantrolene sodium: A review of its pharmacological properties and therapeutic efficacy in spasticity. Drugs 13:3-23, 1977.
11. 11. Hudgson P, Weightman D: Baclofen in the treatment of spasticity. Br Med J 4:15-17, 1971.
12. 12. Sachais BA, Logue JN, Carey MS: Baclofen: A new antispastic drug. Arch Neurol 34:422-428, 1977.
13. 13. Smith CM: Relaxants of skeletal muscle, in Hofmann FG, Root WS (eds): Physiological Pharmacology. New York, Academic Press Inc, vol 2, 1965, pp 1-96.
14. 14. Henatsch HD, Ingvar DH: Chlorpromazin und Spastizitat: Eine experimentelle elektrophysiologische Untersuchung. Arch Psychiatr Nervenkr 195:77-93, 1956.
15. 15. Maxwell DR, Read MA: The effects of some drugs on the rigidity of the cat due to ischaemic or intercollicular decerebration. Neuropharmacol 11:849-855, 1972.
16. 16. Maxwell DR, Read MA, Sumpter EA: Pharmacology of M + B 18706, a drug which selectively reduces decerebrate rigidity. Br J Pharmacol 50:35-45, 1974.
17. 17. Maxwell DR, Eileen AS: A comparison of the actions of some drugs on decerebrate rigidity, muscle spindle activity and alpha-adrenoceptors. Br J Pharmacol 50:355-363, 1974.
18. 18. Basmajian JV, Szatmari A: Effects of Largactil (chlorpromazine) on human spasticity and electromyogram. Arch Neurol Psychiatry 73A:224-231, 1955.
19. 19. Basmajian JV, Szatmari A: Chlorpromazine and human spasticity: An electromyographic study. Neurology 5B:856-860, 1955.
20. 20. Weintraub MI, Megahed MS, Smith BH: Myotonic-like syndrome in multiple sclerosis. NY State J Med 70:677-679, 1970.
21. 21. Anderson RJ, Raines A: Suppression by diphenylhydantoin of afferent discharges arising in muscle spindles of the triceps surae of the cat. J Pharmcol 191:290-299, 1974.
22. 22. Hershkowitz N, Mahany TM, Baizer L, et al: Phenytoin reduction of extensor tone and gamma motoneuron activity in the decerebrate cat. Neurosci Abs 4:297, 1978.
23. 23. Anderson RJ, Raines A: Suppression of decerebrate rigidity by phenytoin and chlorpromazine. Neurology 26:858-862, 1976.
24. 24. Leavitt LA, Beasley WC: Clinical application of quantitative methods in the study of spasticity. Clin Pharmacol Ther 5:918-941, 1964.
25. 25. Matthews PBC, Rushworth G: The selective effect of procaine on the stretch reflex and tendon jerk of soleus muscle when applied to its nerve. J Physiol 135:245, 1957.
26. 26. Rushworth G: The nature and management of spasticity. Proc R Soc Med 57:715-720, 1964.
27. 27. Dimitrijevic MR, Nathan PW: Studies of spasticity in man: I. Some features of spasticity. Brain 90A:1-30, 1967.
28. 28. Dimitrijevic MR, Nathan PW: Studies of spasticity in man: II Analysis of stretch reflexes in spasticity. Brain 90B:333-358, 1967.
29. 29. Macht MB, Kuhn RA: The occurrence of extensor spasm in patients with complete transection of the spinal cord. N Engl J Med 238:311-314, 1948.
30. 30. Polloch LJ, Boshes B, Finkelman I, et al: Management of residuals of injuries to spinal cord and cauda equina. JAMA 146:1551-1563, 1951.
31. 31. Jacobi HM, Krott HM, Poremba MP: Recording of proprioceptive muscle afferents in man by various disorders of tendon reflex. Electromyography 10:307-316, 1970.
32. 32. Borg D, Szomski AJ, Struppler S, et al: Afferent and efferent activation of human muscle receptors involved in reflex and voluntary contraction. Exp Neurol 41:754-768, 1973.
33. 33. Szumski AJ, Burg D, Struppler A, et al: Activity of muscle spindles during muscle twitch and clonus in normal and spastic human subjects. Electroencephalogr Clin Neurophysiol 37:589-597, 1974.
34. 34. Dietrichson P: Phasic ankle reflex in spasticity and parkinsonian rigidity. Acta Neurol Scand 47A:22-51, 1971.
35. 35. Dietrichson P: Tonic ankle reflex in parkinsonian rigidity and in spasticity: The possible role of the fusimotor system. Acta Neurol Scand 47B:163-182, 1971.
36. 36. Dietrichson P: The role of the fusimotor system in spasticity and parkinsonian rigidity, in Desmedt JE (ed): New Developments in Electromyography and Clinical Neurophysiology. New York, S. Karger, 1973, vol 3, pp 496-507.
37. 37. Phillips SJ, Richens A, Shand DG: Adrenergic control of tendon jerk reflexes in man. Br J Pharmacol 47:595-605, 1973.
38. 38. Matthews WB: The action of chlorproethazine on spasticity. Brain 88:1057-1064, 1965.
39. 39. Ellaway PH, Pascoe JE: Noradrenaline as a transmitter in the spinal cord. J Physiol 197:8-10P, 1968.
40. 40. Keary EM, Maxwell DR: A comparison of the effects of chlorpromazine and some related phenothiazines in reducing the rigidity of the decerebrate cat and in some other central actions. Br J Pharmacol Chemother 29:400-416, 1967.
41. 41. Dahlstrom A, Fuxe K: Evidence for the existence of monamine neurons in the central nervous system. Acta Physiol Scand 64(suppl 247):1-85, 1965.
42. 42. Anden NE, Haggendal J, Magnussen T, et al: The time-course of the disappearance of noradrenaline and 5-hydroxytryptamine in the spinal cord after transection. Acta Physiol Scand 62, 115-118, 1964.
43. 43. Bjorklund A, Nobin A: Fluoresence histochemical and microspectrofluorometric: Mapping of dopamine and noradrenaline cell groups in the rat diencephalon. Brain Res 51:193-205, 1973.
44. 44. Anden NE, Jukes MGM, Lundberg A, et al: The effect of DOPA on the spinal cord: I. Influence on transmission from primary afferents. Acta Physiol Scand 67:373-386, 1966.
45. 45. Anden NE, Jukes MGM, Lundberg A: The effect of DOPA on the spinal cord: II. A pharmacological analysis. Acta Physiol Scand 67:387-397, 1966.
46. 46. Anden NE, Jukes MGM, Lundberg A, et al: The effect of DOPA on the spinal cord: III. Depolarization evoked in the central terminals of ipsilateral la afferents by volleys in the flexor reflex afferents. Acta Physiol Scand 68:322-336, 1966.
47. 47. Grillner S: The influence of DOPA on the static and dynamic fusimotor activity of the triceps surae of the spinal cat. Acta Physiol Scand 77:490-509, 1969.
48. 48. Brunia CHM: The influence of diazepam and chlorpromazine on the Achilles tendon and heel reflexes, in Desmedt JE (ed): New Developments in EMG and Clinical Neurophysiology. Basle, Switzerland, S. Karger, 1973, pp 367-370.
49. 49. Landau WM, Weaver RA, Hornbein TF: Fusimotor nerve function in man: Differential nerve block studies in normal subjects and in spasticity and rigidity. Arch Neurol 3:10-23, 1960.
50. 50. Landau WM, Clare MH: Fusimotor function: VI. H reflex, tendon jerk, and reinforcement in hemiplegia. Arch Neurol 10:128-134, 1964.